retatrutide fat loss clinical trial results 🚨 TRIUMPH-1 Phase 3 top-line results, much awaited and just announced ⬇️ 28.3% Weight at 80 weeks ⬇️ 30.3% weight loss at 104 weeks among adults with baseline BMI >35 Eli Lilly infiltrates anti-obesity market

Weight loss also drives sales of aesthetic treatments, including dermal fillers and skin-tightening procedures

In fact, they report that about 2540% of the weight lost on GLP-1 drugs is fat-free mass (muscle and other lean tissue), a much higher fraction than typically seen with diet-and-exercise weight loss

This is an application that has a completely different magnitude of use rates and thus, overall consequences for long-term side effects

It means they provide gentle support without the stronger effects of prescription hormones

Storage duration and conditions are determined by product-specific stability testing, and the only authoritative source of storage instructions for retatrutide is your clinical trial protocol, study sponsor, or dispensing pharmacy